More importantly, COVID-19 progression and severity have been closely correlated with the active status of inflammasomes and the levels of proinflammatory cytokines including interleukin (IL)-1β and IL-18 (24, 25), stressing the potential role of inflammasomes in the pathophysiology of COVID-19-associated systemic complications. The gene discussed is IL1B; the disease is COVID-19.